- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abionyx Pharma SA (ABNX)
Abionyx Pharma SA stock price live, this page displays EPA ABNX stock exchange data. View the ABNX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abionyx Pharma SA real time stock price chart below.
What Is the Abionyx Pharma SA Stock Price Today?
The Abionyx Pharma SA stock price today is 1.2000.
What Is the Stock Symbol for Abionyx Pharma SA?
The stock symbol for Abionyx Pharma SA is ""ABNX.""
What Stock Exchange Does Abionyx Pharma SA Trade On?
Abionyx Pharma SA is listed and trades on the Paris stock exchange.
Is Abionyx Pharma SA a Good Stock to Buy?
Determining whether Abionyx Pharma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABNX quote. (ISIN: FR0012616852)
What Is the Abionyx Pharma SA Stock Price Today?
The Abionyx Pharma SA stock price today is 1.2000.
What Is the Stock Symbol for Abionyx Pharma SA?
The stock symbol for Abionyx Pharma SA is ""ABNX.""
What Stock Exchange Does Abionyx Pharma SA Trade On?
Abionyx Pharma SA is listed and trades on the Paris stock exchange.
Is Abionyx Pharma SA a Good Stock to Buy?
Determining whether Abionyx Pharma SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABNX quote. (ISIN: FR0012616852)
Paris
Currency in EUR
1.2000
-0.0100(-0.83%)
Closed·
Fair Value
An estimate of a Abionyx Pharma SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1960
1.2200
52 wk Range
1.0860
1.5000
ABNX Scorecard
Full Analysis
Stock generally trades with low price volatility
ABNX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Abionyx Pharma SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.19601.2200
52 wk Range
1.08601.5000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABNX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Abionyx Pharma SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
10.7500
Upside
+795.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Abionyx Pharma SA Company Profile
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle that contains human recombinant apoA-I, the natural high-density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimic the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis (NASH). The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is headquartered in Balma, France.
Compare ABNX to Peers and Sector
Metrics to compare | ABNX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABNXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.5x | −1.9x | −0.5x | |
PEG Ratio | 1.14 | 0.03 | 0.00 | |
Price/Book | 5.5x | 1.3x | 2.6x | |
Price / LTM Sales | 9.1x | 3.4x | 3.2x | |
Upside (Analyst Target) | - | 192.6% | 45.4% | |
Fair Value Upside | Unlock | 12.4% | 6.9% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.7500
(+795.83% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
1.00M / --
People Also Watch
FAQ
What Stock Exchange Does Abionyx Pharma SA Trade On?
Abionyx Pharma SA is listed and trades on the Paris Stock Exchange stock exchange.
What Is the Stock Symbol for Abionyx Pharma SA?
The stock symbol for Abionyx Pharma SA is "ABNX."
What Is the Abionyx Pharma SA Market Cap?
As of today, Abionyx Pharma SA market cap is 41.61M.
What Is Abionyx Pharma SA's Earnings Per Share (TTM)?
The Abionyx Pharma SA EPS (TTM) is -0.13.
When Is the Next Abionyx Pharma SA Earnings Date?
Abionyx Pharma SA will release its next earnings report on 24 Sept 2025.
From a Technical Analysis Perspective, Is ABNX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Abionyx Pharma SA Stock Split?
Abionyx Pharma SA has split 0 times.
How Many Employees Does Abionyx Pharma SA Have?
Abionyx Pharma SA has 51 employees.
What is the current trading status of Abionyx Pharma SA (ABNX)?
As of 13 Jul 2025, Abionyx Pharma SA (ABNX) is trading at a price of 1.20, with a previous close of 1.21. The stock has fluctuated within a day range of 1.20 to 1.22, while its 52-week range spans from 1.09 to 1.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.